Gyre Therapeutics Inc

The current institutional shareholding score of Gyre Therapeutics Inc is 3.00, ranking 193 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 4.74%, representing a quarter-over-quarter increase of 36.23%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 2.62K shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.